[Therapeutic apheresis in the treatment of drug-resistant primary glomerulonephritis].
Sakai
S
S
2nd Department of Medicine, Jikei University School of Medicine.
Sakai
O
O
D000293:Adolescent; D000328:Adult; D000936:Antigen-Antibody Complex / Q000302:isolation & purification; D001781:Blood Component Removal; D004351:Drug Resistance; D005260:Female; D005921:Glomerulonephritis / Q000628:therapy*; D015432:Glomerulonephritis, Membranoproliferative / Q000628:therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000628:therapy; D006801:Humans; D007070:Immunoglobulin A / Q000302:isolation & purification; D008077:Lipoproteins, LDL / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged
D000936:Antigen-Antibody Complex; D007070:Immunoglobulin A; D008077:Lipoproteins, LDL